Bilateral Optic Neuritis Secondary to Immune Etiology by anti-PD-L1 Antibody
Authors:
- Mikel Vicente-PascualMVMikel Vicente-Pascual
- Cristina Molins-RojasCMCristina Molins-Rojas
- Katiuska Rosas-SotoKatiuska Rosas-Soto
- Eleonor P. Murata-YonamineEMEleonor P. Murata-Yonamine
- Daniel Vázquez-JustesDVDaniel Vázquez-Justes
- Francisco PurroyFrancisco Purroy
- Alicia Traveset-MaesoATAlicia Traveset-Maeso
- 28 August 2020
- journal article
- editorial
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Optic Neuritis Possibly Induced by Anti-PD-L1 Antibody Treatment in a Patient with Non-Small Cell Lung CarcinomaCase Reports in Ophthalmology, 2018
- CHECKPOINT INHIBITOR IMMUNE THERAPYRetina, 2018
- Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first reportBMC Cancer, 2018
- Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive MelanomaJournal of Clinical Oncology, 2013